Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial

  1. Muñoz-Rivas, N.
  2. Aibar, J.
  3. Gabara-Xancó, C.
  4. Trueba-Vicente, Á.
  5. Urbelz-Pérez, A.
  6. Gómez-Del Olmo, V.
  7. Demelo-Rodríguez, P.
  8. Rivera-Gallego, A.
  9. Bosch-Nicolau, P.
  10. Perez-Pinar, M.
  11. Rios-Prego, M.
  12. Madridano-Cobo, O.
  13. Ramos-Alonso, L.
  14. Alonso-Carrillo, J.
  15. Francisco-Albelsa, I.
  16. Martí-Saez, E.
  17. Maestre-Peiró, A.
  18. Méndez-Bailón, M.
  19. Hernández-Rivas, J.Á.
  20. Torres-Macho, J.
Aldizkaria:
Journal of Clinical Medicine

ISSN: 2077-0383

Argitalpen urtea: 2022

Alea: 11

Zenbakia: 19

Mota: Artikulua

DOI: 10.3390/JCM11195632 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus